These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7561204)

  • 1. Evaluation of a two-phase scid mouse model preconditioned with anti-interferon-gamma monoclonal antibody for drug testing against Cryptosporidium parvum.
    Tzipori S; Rand W; Theodos C
    J Infect Dis; 1995 Oct; 172(4):1160-4. PubMed ID: 7561204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gamma interferon gene knockout mouse: a highly sensitive model for evaluation of therapeutic agents against Cryptosporidium parvum.
    Griffiths JK; Theodos C; Paris M; Tzipori S
    J Clin Microbiol; 1998 Sep; 36(9):2503-8. PubMed ID: 9705383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency.
    Kuhls TL; Mosier DA; Abrams VL; Crawford DL; Greenfield RA
    J Parasitol; 1994 Jun; 80(3):480-5. PubMed ID: 7515109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
    Asadpour M; Namazi F; Razavi SM; Nazifi S
    Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection.
    Aguirre SA; Perryman LE; Davis WC; McGuire TC
    J Immunol; 1998 Aug; 161(4):1891-900. PubMed ID: 9712058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice.
    Chen W; Harp JA; Harmsen AG; Havell EA
    Infect Immun; 1993 Aug; 61(8):3548-51. PubMed ID: 8335387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin: A promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice.
    Asadpour M; Namazi F; Razavi SM; Nazifi S
    Exp Parasitol; 2018 Dec; 195():59-65. PubMed ID: 30385266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
    Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
    Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin.
    Tzipori S; Rand W; Griffiths J; Widmer G; Crabb J
    Clin Diagn Lab Immunol; 1994 Jul; 1(4):450-63. PubMed ID: 8556484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirements for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice.
    Chen W; Harp JA; Harmsen AG
    Infect Immun; 1993 Sep; 61(9):3928-32. PubMed ID: 8103040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticryptosporidial activity of paromomycin.
    Cirioni O; Giacometti A; Balducci M; Drenaggi D; Del Prete MS; Scalise G
    J Infect Dis; 1995 Oct; 172(4):1169-70. PubMed ID: 7561208
    [No Abstract]   [Full Text] [Related]  

  • 12. Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity.
    Ungar BL; Kao TC; Burris JA; Finkelman FD
    J Immunol; 1991 Aug; 147(3):1014-22. PubMed ID: 1677668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum.
    Verdon R; Keusch GT; Tzipori S; Grubman SA; Jefferson DM; Ward HD
    J Infect Dis; 1997 May; 175(5):1268-72. PubMed ID: 9129102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum.
    Healey MC; Yang S; Rasmussen KR; Jackson MK; Du C
    J Parasitol; 1995 Feb; 81(1):114-6. PubMed ID: 7876965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the prophylactic and therapeutic effects of paromomycin, recombinant IL-12 alone or in combination against Cryptosporidium parvum infection in immunosuppressed mice.
    Gamra MM; el-Hosseiny LM
    J Egypt Soc Parasitol; 2003 Apr; 33(1):109-22. PubMed ID: 12739805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of calves against cryptosporiosis by oral inoculation with gamma-irradiated Cryptosporidium parvum oocysts.
    Jenkins M; Higgins J; Kniel K; Trout J; Fayer R
    J Parasitol; 2004 Oct; 90(5):1178-80. PubMed ID: 15562625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis.
    Riggs MW; Schaefer DA; Kapil SJ; Barley-Maloney L; Perryman LE
    Antimicrob Agents Chemother; 2002 Feb; 46(2):275-82. PubMed ID: 11796330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of the infectivity of Cryptosporidium parvum by monitoring the oocyst discharge from SCID mice.
    Hikosaka K; Satoh M; Koyama Y; Nakai Y
    Vet Parasitol; 2005 Nov; 134(1-2):173-6. PubMed ID: 16076530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of mangiferin against Cryptosporidium parvum in a neonatal mouse model.
    Perrucci S; Fichi G; Buggiani C; Rossi G; Flamini G
    Parasitol Res; 2006 Jul; 99(2):184-8. PubMed ID: 16547730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles for NK cells and an NK cell-independent source of intestinal gamma interferon for innate immunity to Cryptosporidium parvum infection.
    Barakat FM; McDonald V; Di Santo JP; Korbel DS
    Infect Immun; 2009 Nov; 77(11):5044-9. PubMed ID: 19687195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.